ferrous fumarate 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Stem definitionDrug idCAS RN
4261 141-01-5

Description:

MoleculeDescription

Synonyms:

  • ferrous fumarate
  • iron fumarate
used in treatment of iron deficiency anemia; RN given refers to Fe(+2)[1:1] salt
  • Molecular weight: 169.90
  • Formula: C4H2FeO4
  • CLOGP:
  • LIPINSKI: None
  • HAC: None
  • HDO: None
  • TPSA:
  • ALOGS:
  • ROTB: None

Drug dosage:

DoseUnitRoute
0.20 g O

ADMET properties:

None

Predicted pharmacokinetic/toxicological properties (PK-AZ):

None

Approvals:

DateAgencyCompanyOrphan
July 18, 1986 FDA GD SEARLE LLC

FDA Adverse Event Reporting System (Female)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Swelling face 217 10.58 277 63601 81075 90483494
Swollen tongue 213.30 10.58 209 63669 45747 90518822
Hand deformity 178.44 10.58 7 63871 296355 90268214
Glossodynia 174.17 10.58 14 63864 321765 90242804
Dysphonia 165.38 10.58 213 63665 62871 90501698
Pericarditis 160.55 10.58 7 63871 270144 90294425
Fall 151.35 10.58 706 63172 481104 90083465
Angioedema 141.04 10.58 200 63678 64676 90499893
Systemic lupus erythematosus 137.67 10.58 42 63836 361854 90202715
Helicobacter infection 131.18 10.58 7 63871 226843 90337726
Infusion related reaction 129.62 10.58 66 63812 416714 90147855
Folliculitis 125.85 10.58 4 63874 204349 90360220
Wound 122.99 10.58 31 63847 302949 90261620
Haematocrit decreased 118.76 10.58 147 63731 41685 90522884
Haemoglobin decreased 115.16 10.58 311 63567 161645 90402924
Red blood cell count decreased 112.94 10.58 151 63727 46200 90518369
Irritable bowel syndrome 88.57 10.58 19 63859 207429 90357140
Drug ineffective for unapproved indication 86.88 10.58 163 63715 66481 90498088
General physical health deterioration 86.37 10.58 74 63804 355041 90209528
Product use issue 86.19 10.58 64 63814 329855 90234714
Red blood cell sedimentation rate abnormal 83.52 10.58 94 63784 24110 90540459
Liver injury 83.01 10.58 11 63867 170556 90394013
Blister 82.84 10.58 38 63840 254960 90309609
Multiple fractures 82.35 10.58 62 63816 9500 90555069
Rheumatoid factor positive 81.35 10.58 12 63866 171638 90392931
Sleep disorder due to general medical condition, insomnia type 77.54 10.58 3 63875 128691 90435878
Hepatic enzyme increased 77.45 10.58 84 63794 360652 90203917
Type 2 diabetes mellitus 74.72 10.58 25 63853 203219 90361350
Maternal exposure during pregnancy 73.86 10.58 87 63791 359976 90204593
Discomfort 73.23 10.58 52 63826 274283 90290286
Diarrhoea 66.07 10.58 977 62901 938213 89626356
Ill-defined disorder 65.80 10.58 24 63854 184867 90379702
Alopecia 64.47 10.58 160 63718 494911 90069658
Fibromyalgia 63.55 10.58 33 63845 206236 90358333
Joint range of motion decreased 63.09 10.58 10 63868 135633 90428936
Therapeutic product effect decreased 60.26 10.58 64 63814 277507 90287062
Abdominal discomfort 60.03 10.58 157 63721 477171 90087398
Malignant mediastinal neoplasm 59.91 10.58 26 63852 1382 90563187
Synovitis 58.15 10.58 89 63789 329663 90234906
Swelling 56.46 10.58 133 63745 418925 90145644
Hip fracture 56.28 10.58 91 63787 32986 90531583
Hypercholesterolaemia 55.64 10.58 4 63874 100888 90463681
Headache 54.67 10.58 882 62996 861864 89702705
Femur fracture 53.09 10.58 107 63771 45975 90518594
Intentional product use issue 52.93 10.58 45 63833 216847 90347722
Blood cholesterol increased 50.95 10.58 43 63835 207969 90356600
Product use in unapproved indication 50.85 10.58 100 63778 336136 90228433
Bursitis 50.51 10.58 15 63863 131639 90432930
Obesity 48.56 10.58 8 63870 105499 90459070
Toxicity to various agents 48.55 10.58 80 63798 287766 90276803
Device expulsion 48.38 10.58 96 63782 40790 90523779
C3 glomerulopathy 47.53 10.58 13 63865 164 90564405
Grip strength decreased 47.44 10.58 5 63873 92571 90471998
Treatment failure 47.17 10.58 89 63789 303839 90260730
Full blood count decreased 46.90 10.58 79 63799 29610 90534959
Product dose omission issue 46.34 10.58 358 63520 291329 90273240
Fatigue 45.17 10.58 1097 62781 1152926 89411643
Wound infection 44.88 10.58 10 63868 106392 90458177
Unevaluable event 44.78 10.58 111 63767 54737 90509832
Peripheral venous disease 44.40 10.58 4 63874 83917 90480652
Clostridium test positive 44.26 10.58 34 63844 5367 90559202
Presbyacusis 43.54 10.58 27 63851 3015 90561554
Stomatitis 41.26 10.58 82 63796 274616 90289953
Full blood count abnormal 41.00 10.58 84 63794 36513 90528056
Blood pressure measurement 40.75 10.58 14 63864 392 90564177
Dizziness 39.32 10.58 608 63270 588676 89975893
Lower respiratory tract infection 39.24 10.58 73 63805 250586 90313983
Acute kidney injury 39.17 10.58 371 63507 320016 90244553
Mobility decreased 38.39 10.58 74 63804 250660 90313909
Neoplasm skin 37.81 10.58 25 63853 3117 90561452
Nasal congestion 37.74 10.58 137 63741 83277 90481292
Constipation 37.47 10.58 331 63547 280064 90284505
Dehydration 37.43 10.58 250 63628 194197 90370372
Device dislocation 37.34 10.58 74 63804 31408 90533161
Neuropathy peripheral 37.31 10.58 193 63685 136777 90427792
Pleural thickening 37.06 10.58 25 63853 3223 90561346
Lethargy 36.84 10.58 113 63765 63026 90501543
Blood magnesium increased 35.97 10.58 25 63853 3383 90561186
Lung disorder 35.47 10.58 32 63846 149851 90414718
Feeling abnormal 35.24 10.58 220 63658 167015 90397554
Deep vein thrombosis 34.52 10.58 142 63736 91478 90473091
Hypertension 34.27 10.58 186 63692 457346 90107223
Therapy cessation 33.36 10.58 77 63801 36284 90528285
Autoimmune disorder 32.80 10.58 7 63871 76737 90487832
Pleural fibrosis 32.49 10.58 24 63854 3572 90560997
Blood immunoglobulin E increased 32.26 10.58 26 63852 4399 90560170
Contraindicated product administered 31.89 10.58 117 63761 320022 90244547
Psoriatic arthropathy 31.09 10.58 72 63806 228263 90336306
Night sweats 31.06 10.58 27 63851 128739 90435830
Prescribed overdose 30.98 10.58 15 63863 97610 90466959
Live birth 30.36 10.58 9 63869 79098 90485471
Large intestine polyp 29.93 10.58 35 63843 9351 90555218
Arthropathy 29.03 10.58 146 63732 366096 90198473
Hyponatraemia 28.96 10.58 177 63701 133361 90431208
Pelvic kidney 28.96 10.58 8 63870 105 90564464
Cyst 28.77 10.58 46 63832 16515 90548054
Dyspnoea 28.72 10.58 818 63060 880137 89684432
Blood potassium increased 28.60 10.58 52 63826 20697 90543872
Myalgia 28.37 10.58 216 63662 174909 90389660
Exposure during pregnancy 27.99 10.58 81 63797 238329 90326240
Infection 27.77 10.58 146 63732 361948 90202621
Disability 27.68 10.58 77 63801 40668 90523901
Back pain 27.07 10.58 342 63536 316833 90247736
Intentional overdose 26.06 10.58 17 63861 93817 90470752
Urine protein/creatinine ratio increased 25.45 10.58 13 63865 999 90563570
Epigastric discomfort 25.44 10.58 29 63849 7539 90557030
Neutrophil count 25.31 10.58 10 63868 418 90564151
Muscle spasms 25.19 10.58 280 63598 251603 90312966
Sciatica 24.76 10.58 21 63857 101361 90463208
Metabolic encephalopathy 24.63 10.58 27 63851 6725 90557844
Hypophagia 24.50 10.58 68 63810 35869 90528700
Tremor 24.29 10.58 188 63690 152985 90411584
Drug ineffective 24.21 10.58 768 63110 1383530 89181039
Blood lactic acid 24.00 10.58 7 63871 113 90564456
Injury 23.94 10.58 66 63812 197283 90367286
Pulmonary embolism 23.85 10.58 166 63712 130654 90433915
Blepharospasm 23.81 10.58 5 63873 55440 90509129
Plasma cell myeloma 23.75 10.58 73 63805 40755 90523814
Osteopenia 23.67 10.58 51 63827 22951 90541618
Starvation ketoacidosis 23.53 10.58 8 63870 217 90564352
Pain in extremity 23.52 10.58 447 63431 450082 90114487
Overdose 22.88 10.58 48 63830 157661 90406908
Productive cough 22.67 10.58 111 63767 76952 90487617
Myelosuppression 22.67 10.58 5 63873 53586 90510983
Upper gastrointestinal haemorrhage 22.57 10.58 50 63828 22926 90541643
Nail disorder 22.16 10.58 7 63871 59060 90505509
Dysstasia 21.83 10.58 52 63826 25000 90539569
Gastrointestinal haemorrhage 21.75 10.58 123 63755 90125 90474444
Flatulence 21.36 10.58 71 63807 41296 90523273
Urinary tract infection 21.35 10.58 318 63560 305314 90259255
Therapy non-responder 21.21 10.58 40 63838 136664 90427905
Impaired healing 21.14 10.58 89 63789 234110 90330459
Nausea 20.90 10.58 969 62909 1109347 89455222
Thyroiditis acute 20.56 10.58 6 63872 97 90564472
Pelvic pain 20.55 10.58 38 63840 15319 90549250
Hippocampal sclerosis 20.45 10.58 6 63872 99 90564470
Vaginal haemorrhage 20.17 10.58 58 63820 31213 90533356
Atrial fibrillation 20.09 10.58 162 63716 133449 90431120
Therapeutic product effect incomplete 19.87 10.58 70 63808 193826 90370743
Urticaria 19.79 10.58 134 63744 312600 90251969
Lupus-like syndrome 19.79 10.58 5 63873 48841 90515728
Cough 19.56 10.58 367 63511 368595 90195974
Narrow anterior chamber angle 19.43 10.58 5 63873 49 90564520
Deafness neurosensory 19.34 10.58 24 63854 6817 90557752
Intentional product misuse 19.05 10.58 21 63857 89583 90474986
Cerebellar haematoma 19.05 10.58 8 63870 392 90564177
Blindness cortical 19.02 10.58 9 63869 586 90563983
Epilepsy 18.91 10.58 18 63860 82188 90482381
Cerebrovascular accident 18.69 10.58 150 63728 123383 90441186
Dysgeusia 18.65 10.58 80 63798 52480 90512089
Blood potassium decreased 17.99 10.58 74 63804 47653 90516916
Lower limb fracture 17.99 10.58 20 63858 84993 90479576
Lip swelling 17.96 10.58 64 63814 38546 90526023
Parkinsonian rest tremor 17.74 10.58 6 63872 160 90564409
Postural tremor 17.55 10.58 8 63870 478 90564091
Laryngitis 17.36 10.58 7 63871 50746 90513823
Haemorrhoidal haemorrhage 17.22 10.58 20 63858 5303 90559266
Pulmonary fibrosis 17.08 10.58 31 63847 107472 90457097
Nasopharyngitis 17.07 10.58 194 63684 406910 90157659
Restless legs syndrome 16.80 10.58 44 63834 22426 90542143
International normalised ratio increased 16.77 10.58 72 63806 47244 90517325
Chorea 16.67 10.58 13 63865 2097 90562472
Pneumonia 16.64 10.58 577 63301 637482 89927087
Hip arthroplasty 16.05 10.58 18 63860 76190 90488379
Bone pain 15.95 10.58 86 63792 61897 90502672
Liver disorder 15.89 10.58 39 63839 121230 90443339
Injection site haemorrhage 15.88 10.58 50 63828 28268 90536301
Skin depigmentation 15.76 10.58 10 63868 1163 90563406
Eye swelling 15.68 10.58 51 63827 29335 90535234
Melaena 15.60 10.58 57 63821 34740 90529829
Heart rate 15.53 10.58 6 63872 236 90564333
Pulmonary arterial hypertension 15.39 10.58 47 63831 26140 90538429
Product quality issue 15.36 10.58 20 63858 79305 90485264
Gastrointestinal disorder 15.25 10.58 112 63766 256575 90307994
Sleep disorder 15.08 10.58 80 63798 197950 90366619
Knee arthroplasty 15.08 10.58 22 63856 83160 90481409
Drug hypersensitivity 15.03 10.58 233 63645 463376 90101193
Ear infection viral 14.98 10.58 5 63873 128 90564441
AST/ALT ratio abnormal 14.90 10.58 5 63873 130 90564439
Rhinorrhoea 14.90 10.58 110 63768 88206 90476363
Hypomagnesaemia 14.88 10.58 57 63821 35531 90529038
Haemorrhoids 14.84 10.58 47 63831 26655 90537914
Eye pain 14.74 10.58 66 63812 44102 90520467
Blood creatinine increased 14.74 10.58 122 63756 101264 90463305
Psoriasis 14.64 10.58 164 63714 147590 90416979
Vision blurred 14.60 10.58 130 63748 110163 90454406
Dyspnoea exertional 14.53 10.58 94 63784 72194 90492375
Adverse event 14.43 10.58 39 63839 117379 90447190
Skin neoplasm excision 14.33 10.58 11 63867 1735 90562834
Hot flush 14.28 10.58 81 63797 59407 90505162
Hypoaesthesia oral 14.27 10.58 33 63845 15567 90549002
Rheumatoid lung 14.26 10.58 16 63862 4087 90560482
Gait inability 14.26 10.58 54 63824 146402 90418167
Hypervolaemia 14.14 10.58 53 63825 32704 90531865
Megacolon 14.04 10.58 12 63866 2202 90562367
Heart rate abnormal 13.85 10.58 19 63859 5952 90558617
Suicide attempt 13.61 10.58 20 63858 75379 90489190
Withdrawal of life support 13.58 10.58 4 63874 67 90564502
Clostridium difficile infection 13.51 10.58 56 63822 36189 90528380
Uterine leiomyoma 13.44 10.58 26 63852 10838 90553731
New onset diabetes after transplantation 13.39 10.58 5 63873 179 90564390
Faeces discoloured 13.23 10.58 39 63839 21281 90543288
Immunodeficiency 13.18 10.58 7 63871 43227 90521342
Myotonia 13.11 10.58 5 63873 190 90564379
Off label use 12.99 10.58 640 63238 1101612 89462957
Abdominal pain 12.98 10.58 368 63510 395353 90169216
Infected neoplasm 12.89 10.58 6 63872 376 90564193
Keratitis 12.88 10.58 15 63863 3991 90560578
Occult blood positive 12.82 10.58 15 63863 4008 90560561
Influenza like illness 12.80 10.58 99 63779 80512 90484057
Polyhydramnios 12.75 10.58 12 63866 2496 90562073
Abdominal hernia 12.70 10.58 18 63860 5810 90558759
Foot deformity 12.66 10.58 14 63864 59637 90504932
Balance disorder 12.63 10.58 114 63764 96966 90467603
Intracranial haematoma 12.63 10.58 6 63872 394 90564175
Potassium hydroxide preparation positive 12.55 10.58 3 63875 21 90564548
Coeliac disease 12.50 10.58 8 63870 44602 90519967
Skin discolouration 12.44 10.58 63 63815 44252 90520317
Photosensitivity reaction 12.44 10.58 34 63844 17773 90546796
Cardiac failure congestive 12.39 10.58 115 63763 98579 90465990
Temporal lobe epilepsy 12.28 10.58 6 63872 419 90564150
Pain 12.22 10.58 576 63302 995765 89568804
Clostridium difficile colitis 12.19 10.58 44 63834 26662 90537907
Reperfusion arrhythmia 12.12 10.58 5 63873 234 90564335
Hypoxia 12.11 10.58 90 63788 72309 90492260
Laboratory test abnormal 12.10 10.58 60 63818 41794 90522775
White blood cell count decreased 12.10 10.58 175 63703 166934 90397635
Dry eye 12.06 10.58 76 63802 57855 90506714
Liver function test abnormal 12.05 10.58 69 63809 50776 90513793
Rash pruritic 11.98 10.58 99 63779 82115 90482454
Hepatobiliary infection 11.79 10.58 3 63875 28 90564541
Mental impairment 11.75 10.58 32 63846 16688 90547881
Product complaint 11.74 10.58 28 63850 13472 90551097
Haematemesis 11.71 10.58 51 63827 33675 90530894
Urinary incontinence 11.69 10.58 55 63823 37511 90527058
Vulvovaginal mycotic infection 11.61 10.58 18 63860 6296 90558273
Failure to thrive 11.49 10.58 21 63857 8390 90556179
Onychomycosis 11.47 10.58 6 63872 37370 90527199
Rash macular 11.45 10.58 47 63831 30233 90534336
Administration site swelling 11.34 10.58 9 63869 1490 90563079
Dry skin 11.25 10.58 103 63775 87970 90476599
Joint dislocation 11.17 10.58 9 63869 44573 90519996
Thrombosis 11.11 10.58 89 63789 73162 90491407
Cytokine release syndrome 11.07 10.58 3 63875 27970 90536599
Post procedural discharge 11.03 10.58 6 63872 524 90564045
Hyperkalaemia 11.00 10.58 81 63797 64883 90499686
Chromaturia 10.87 10.58 34 63844 19153 90545416
Cellulitis 10.76 10.58 105 63773 91232 90473337
Drug resistance 10.74 10.58 4 63874 30445 90534124
Orthostatic hypotension 10.74 10.58 58 63820 41769 90522800
Aura 10.72 10.58 8 63870 1209 90563360
Skin cancer 10.65 10.58 27 63851 13492 90551077
Hepatotoxicity 10.59 10.58 10 63868 45832 90518737

FDA Adverse Event Reporting System (Male)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Clear cell renal cell carcinoma 88.13 11.20 34 32037 1247 42588017
Off label use 79.00 11.20 234 31837 638101 41951163
Fall 72.95 11.20 359 31712 234161 42355103
Lymphoproliferative disorder 62.69 11.20 36 32035 3271 42585993
Drug ineffective 59.29 11.20 259 31812 629938 41959326
Completed suicide 51.70 11.20 6 32065 96459 42492805
Toxicity to various agents 49.28 11.20 60 32011 229076 42360188
Fatigue 47.86 11.20 519 31552 435122 42154142
Product use in unapproved indication 46.74 11.20 42 32029 184414 42404850
Plasma cell myeloma 41.72 11.20 103 31968 47475 42541789
Full blood count decreased 35.48 11.20 59 32012 20501 42568763
Diarrhoea 35.10 11.20 513 31558 460336 42128928
Asthenia 32.34 11.20 338 31733 280455 42308809
Psoriasis 29.49 11.20 92 31979 48512 42540752
Congenital oesophageal anomaly 29.33 11.20 8 32063 93 42589171
Laboratory test abnormal 28.31 11.20 57 32014 22921 42566343
Intentional product misuse 28.31 11.20 6 32065 61894 42527370
Meconium abnormal 26.44 11.20 7 32064 72 42589192
Dizziness 26.34 11.20 295 31776 248959 42340305
Autoscopy 25.52 11.20 9 32062 255 42589009
Drug interaction 24.18 11.20 111 31960 266888 42322376
Multiple organ dysfunction syndrome 23.49 11.20 23 32048 97012 42492252
White blood cell count decreased 22.98 11.20 152 31919 110244 42479020
Clostridium test positive 22.31 11.20 24 32047 5481 42583783
Product dose omission issue 22.28 11.20 195 31876 154170 42435094
General physical health deterioration 21.93 11.20 51 32020 151195 42438069
Polyhydramnios 21.79 11.20 8 32063 255 42589009
Confusional state 21.79 11.20 207 31864 167390 42421874
Abdominal symptom 21.71 11.20 10 32061 573 42588691
Paraneoplastic rash 20.72 11.20 6 32065 88 42589176
High frequency ablation 20.53 11.20 7 32064 179 42589085
Muscle spasms 20.09 11.20 122 31949 85922 42503342
Intentional overdose 19.76 11.20 7 32064 51449 42537815
Apnoeic attack 19.66 11.20 9 32062 508 42588756
Pneumonia 19.63 11.20 435 31636 421714 42167550
Caput succedaneum 19.42 11.20 6 32065 111 42589153
COVID-19 18.55 11.20 37 32034 115911 42473353
Viral infection 17.96 11.20 47 32024 22436 42566828
Adverse drug reaction 17.54 11.20 65 32006 37369 42551895
Treatment failure 17.40 11.20 13 32058 62611 42526653
Blood magnesium decreased 17.29 11.20 25 32046 7701 42581563
Abdominal pain 17.26 11.20 219 31852 190252 42399012
Cytokine release syndrome 17.20 11.20 6 32065 44521 42544743
Hepatic function abnormal 16.67 11.20 9 32062 51558 42537706
Necrotising enterocolitis neonatal 16.60 11.20 7 32064 324 42588940
Gastrointestinal haemorrhage 15.98 11.20 127 31944 97599 42491665
Lymphoedema 15.69 11.20 19 32052 4929 42584335
Hallucination 15.69 11.20 85 31986 57422 42531842
Renal cell carcinoma 15.60 11.20 20 32051 5497 42583767
Dependence on oxygen therapy 15.35 11.20 6 32065 228 42589036
Constipation 15.30 11.20 188 31883 162103 42427161
Spinal epidural haemorrhage 15.03 11.20 4 32067 42 42589222
Small intestinal obstruction 15.01 11.20 37 32034 17024 42572240
Suicide attempt 14.96 11.20 8 32063 46092 42543172
Swelling face 14.76 11.20 50 32021 27504 42561760
Upper gastrointestinal haemorrhage 14.52 11.20 53 32018 30246 42559018
Haemorrhoids thrombosed 14.39 11.20 6 32065 270 42588994
Weight decreased 14.39 11.20 228 31843 207720 42381544
Agitated depression 14.35 11.20 6 32065 272 42588992
Epileptic encephalopathy 13.97 11.20 6 32065 291 42588973
Hip fracture 13.80 11.20 31 32040 13441 42575823
Microcytic anaemia 13.67 11.20 14 32057 3021 42586243
Haemoglobin decreased 13.60 11.20 156 31915 132315 42456949
Drug ineffective for unapproved indication 13.59 11.20 9 32062 46154 42543110
Iron deficiency anaemia 13.35 11.20 30 32041 13009 42576255
Cytomegalovirus infection 13.10 11.20 4 32067 32302 42556962
Faeces discoloured 13.01 11.20 35 32036 16979 42572285
Malaise 12.98 11.20 228 31843 211928 42377336
Drug resistance 12.58 11.20 5 32066 34243 42555021
Interstitial lung disease 12.57 11.20 25 32046 78437 42510827
Influenza 12.56 11.20 85 31986 62090 42527174
Oedema peripheral 12.55 11.20 157 31914 135919 42453345
Peripheral swelling 12.47 11.20 113 31958 90157 42499107
Unevaluable event 12.45 11.20 55 32016 34233 42555031
Condition aggravated 12.35 11.20 131 31940 260623 42328641
Cardiac flutter 11.75 11.20 11 32060 2129 42587135
Tongue coated 11.70 11.20 6 32065 435 42588829
Monoclonal immunoglobulin increased 11.61 11.20 6 32065 442 42588822
Back pain 11.58 11.20 160 31911 141616 42447648
Femoral neck fracture 11.50 11.20 15 32056 4194 42585070
Testicular haemorrhage 11.46 11.20 5 32066 252 42589012
Pneumonia haemophilus 11.22 11.20 8 32063 1056 42588208

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Swelling face 222.37 10.19 304 80201 92017 110416777
Fall 196.34 10.19 914 79591 602568 109906226
Swollen tongue 184.99 10.19 224 80281 60138 110448656
Completed suicide 147.03 10.19 7 80498 242374 110266420
Dysphonia 137.95 10.19 219 80286 75710 110433084
Hand deformity 130.34 10.19 7 80498 218499 110290295
Haematocrit decreased 116.41 10.19 188 80317 65929 110442865
Drug abuse 114.96 10.19 3 80502 177408 110331386
Duodenal ulcer perforation 111.55 10.19 4 80501 177696 110331098
Glossodynia 111.09 10.19 15 80490 221989 110286805
Haemoglobin decreased 106.49 10.19 410 80095 248317 110260477
Helicobacter infection 102.05 10.19 8 80497 181869 110326925
Infusion related reaction 102.02 10.19 77 80428 381085 110127709
Red blood cell count decreased 99.51 10.19 175 80330 65748 110443046
Folliculitis 98.05 10.19 6 80499 167647 110341147
Angioedema 95.13 10.19 217 80288 98283 110410511
Pericarditis 92.08 10.19 23 80482 219091 110289703
Toxicity to various agents 91.44 10.19 130 80375 480425 110028369
General physical health deterioration 90.24 10.19 106 80399 425189 110083605
Multiple fractures 88.82 10.19 64 80441 8876 110499918
Systemic lupus erythematosus 85.54 10.19 39 80466 254299 110254495
Product use in unapproved indication 73.80 10.19 133 80372 447244 110061550
Clear cell renal cell carcinoma 72.86 10.19 37 80468 2719 110506075
Red blood cell sedimentation rate abnormal 71.91 10.19 89 80416 24420 110484374
Irritable bowel syndrome 71.43 10.19 16 80489 164199 110344595
Sleep disorder due to general medical condition, insomnia type 64.21 10.19 3 80502 105640 110403154
Clostridium test positive 63.37 10.19 57 80448 10836 110497958
Hip fracture 61.93 10.19 100 80405 35051 110473743
Hepatic enzyme increased 61.80 10.19 86 80419 320806 110187988
Product use issue 61.57 10.19 82 80423 311613 110197181
Dizziness 60.66 10.19 775 79730 697418 109811376
Malignant mediastinal neoplasm 59.64 10.19 26 80479 1352 110507442
Rheumatoid factor positive 58.94 10.19 12 80493 131628 110377166
Femur fracture 58.19 10.19 111 80394 44358 110464436
Device expulsion 57.33 10.19 90 80415 30801 110477993
Liver injury 57.27 10.19 19 80486 150394 110358400
Wound 56.95 10.19 52 80453 234385 110274409
Ill-defined disorder 56.01 10.19 22 80483 156831 110351963
Blister 53.39 10.19 52 80453 227324 110281470
Joint range of motion decreased 52.72 10.19 12 80493 121820 110386974
Bursitis 52.00 10.19 15 80490 129903 110378891
Fatigue 51.26 10.19 1201 79304 1214757 109294037
Diarrhoea 50.98 10.19 1135 79370 1138370 109370424
Off label use 50.87 10.19 778 79727 1499407 109009387
Drug ineffective 50.40 10.19 792 79713 1519748 108989046
Fibromyalgia 50.39 10.19 31 80474 170878 110337916
Obesity 49.38 10.19 11 80494 113340 110395454
Intentional product misuse 48.52 10.19 18 80487 132886 110375908
Headache 48.37 10.19 906 79599 881471 109627323
Peripheral venous disease 46.34 10.19 4 80501 84113 110424681
Intentional product use issue 46.18 10.19 68 80437 247838 110260956
Myelosuppression 45.72 10.19 7 80498 94333 110414461
Lymphoproliferative disorder 44.44 10.19 39 80466 7179 110501615
Grip strength decreased 43.66 10.19 4 80501 80170 110428624
Maternal exposure during pregnancy 43.60 10.19 74 80431 254809 110253985
Drug ineffective for unapproved indication 43.53 10.19 169 80336 102669 110406125
Plasma cell myeloma 43.34 10.19 122 80383 62814 110445980
Product dose omission issue 42.70 10.19 389 80116 321393 110187401
Dehydration 42.36 10.19 348 80157 279163 110229631
Hypercholesterolaemia 41.25 10.19 8 80497 90829 110417965
Type 2 diabetes mellitus 41.07 10.19 41 80464 177191 110331603
Dyspnoea 40.84 10.19 1074 79431 1105798 109402996
Full blood count decreased 40.62 10.19 79 80426 32020 110476774
Intentional overdose 40.52 10.19 23 80482 132478 110376316
Stomatitis 40.48 10.19 85 80420 270157 110238637
Alopecia 40.00 10.19 134 80371 364619 110144175
Discomfort 39.88 10.19 59 80446 214648 110294146
Synovitis 39.57 10.19 88 80417 274004 110234790
Treatment failure 38.41 10.19 91 80414 277143 110231651
Upper gastrointestinal haemorrhage 38.38 10.19 101 80404 49995 110458799
Lethargy 38.16 10.19 152 80353 93424 110415370
Disability 37.78 10.19 74 80431 30149 110478645
Acute kidney injury 36.69 10.19 658 79847 634772 109874022
Blood pressure measurement 36.67 10.19 14 80491 516 110508278
Blood immunoglobulin E increased 35.56 10.19 35 80470 7447 110501347
Mobility decreased 35.28 10.19 75 80430 237347 110271447
Presbyacusis 34.64 10.19 23 80482 2796 110505998
Neoplasm skin 34.28 10.19 24 80481 3180 110505614
Blood cholesterol increased 34.10 10.19 51 80454 184734 110324060
Therapy cessation 33.92 10.19 90 80415 44767 110464027
Gastrointestinal haemorrhage 33.61 10.19 221 80284 165297 110343497
Hyponatraemia 32.44 10.19 270 80235 217383 110291411
Therapeutic product effect decreased 32.42 10.19 82 80423 244234 110264560
Wound infection 32.09 10.19 15 80490 96450 110412344
Lung disorder 31.97 10.19 51 80454 179996 110328798
Nasal congestion 31.89 10.19 149 80356 98133 110410661
Device dislocation 31.88 10.19 71 80434 31633 110477161
Autoimmune disorder 31.41 10.19 5 80500 65478 110443316
Night sweats 29.90 10.19 32 80473 133951 110374843
Deep vein thrombosis 29.14 10.19 188 80317 139699 110369095
Metabolic encephalopathy 29.02 10.19 38 80467 11022 110497772
Faeces discoloured 28.66 10.19 71 80434 33877 110474917
Blood potassium increased 28.56 10.19 70 80435 33179 110475615
Pleural thickening 28.55 10.19 22 80483 3377 110505417
Psoriatic arthropathy 28.53 10.19 63 80442 196698 110312096
Hypertension 28.47 10.19 236 80269 509848 109998946
Overdose 28.36 10.19 82 80423 233712 110275082
Blood magnesium increased 28.36 10.19 23 80482 3800 110504994
Cytokine release syndrome 28.35 10.19 8 80497 70298 110438496
Lower respiratory tract infection 28.25 10.19 87 80418 243019 110265775
Swelling 27.89 10.19 146 80359 350895 110157899
Live birth 27.84 10.19 8 80497 69476 110439318
Hypophagia 27.81 10.19 93 80412 52533 110456261
Feeling abnormal 27.36 10.19 225 80280 180486 110328308
Blepharospasm 26.73 10.19 4 80501 54847 110453947
Neutrophil count 25.51 10.19 10 80495 396 110508398
Hypervolaemia 24.90 10.19 86 80419 49374 110459420
International normalised ratio increased 24.89 10.19 127 80378 86645 110422149
Constipation 24.85 10.19 382 80123 357404 110151390
Myalgia 24.66 10.19 259 80246 222122 110286672
Back pain 24.59 10.19 393 80112 370603 110138191
Nail disorder 24.48 10.19 6 80499 57929 110450865
Liver disorder 23.67 10.19 42 80463 142201 110366593
Tremor 23.59 10.19 238 80267 201994 110306800
Bone erosion 23.50 10.19 3 80502 46368 110462426
Abdominal pain 23.45 10.19 513 79992 512476 109996318
Epilepsy 23.42 10.19 23 80482 100186 110408608
Sciatica 23.02 10.19 20 80485 92379 110416415
Suicide attempt 22.73 10.19 25 80480 103369 110405425
Unevaluable event 22.40 10.19 94 80411 59133 110449661
Exposure during pregnancy 22.36 10.19 56 80449 167368 110341426
Pain in extremity 22.22 10.19 487 80018 486631 110022163
Pleural fibrosis 22.07 10.19 21 80484 4287 110504507
Haematemesis 21.72 10.19 93 80412 59015 110449779
Therapeutic response decreased 21.58 10.19 23 80482 96476 110412318
Accidental exposure to product 21.48 10.19 5 80500 50003 110458791
Melaena 21.40 10.19 103 80402 68654 110440140
Large intestine polyp 21.35 10.19 39 80466 15078 110493716
Drug interaction 21.34 10.19 247 80258 499936 110008858
Paraneoplastic rash 20.85 10.19 6 80499 89 110508705
Epigastric discomfort 20.66 10.19 29 80476 8986 110499808
Blood potassium decreased 20.55 10.19 86 80419 54028 110454766
COVID-19 20.55 10.19 100 80405 244960 110263834
Cytomegalovirus infection 20.50 10.19 7 80498 54437 110454357
Abdominal discomfort 20.29 10.19 186 80319 393672 110115122
Starvation ketoacidosis 20.10 10.19 8 80497 330 110508464
Pneumonia 20.05 10.19 804 79701 875910 109632884
Drug resistance 19.97 10.19 8 80497 56366 110452428
Full blood count abnormal 19.69 10.19 87 80418 55965 110452829
Lip swelling 19.62 10.19 81 80424 50586 110458208
Therapeutic product effect incomplete 19.54 10.19 90 80415 223715 110285079
Dyspnoea exertional 19.36 10.19 136 80369 103924 110404870
Cardiac failure congestive 19.22 10.19 181 80324 150819 110357975
Nasopharyngitis 19.14 10.19 189 80316 394172 110114622
Cyst 18.95 10.19 39 80466 16457 110492337
Eye swelling 18.90 10.19 60 80445 32988 110475806
Pelvic pain 18.68 10.19 38 80467 15904 110492890
Hospice care 18.67 10.19 33 80472 12440 110496354
Vaginal haemorrhage 18.64 10.19 50 80455 25024 110483770
Atrial fibrillation 18.64 10.19 252 80253 229390 110279404
Coma 18.55 10.19 36 80469 117833 110390961
Muscle spasms 18.55 10.19 295 80210 277862 110230932
Oedema peripheral 18.45 10.19 339 80166 328321 110180473
Asthenia 18.42 10.19 643 79862 688356 109820438
Dysgeusia 18.40 10.19 100 80405 69885 110438909
Prescribed overdose 18.36 10.19 22 80483 87559 110421235
Onychomycosis 18.35 10.19 3 80502 38528 110470266
Hepatic function abnormal 18.12 10.19 23 80482 89272 110419522
Pulmonary arterial hypertension 17.60 10.19 58 80447 32510 110476284
Therapy non-responder 17.08 10.19 58 80447 157249 110351545
Blood magnesium decreased 17.07 10.19 42 80463 19954 110488840
Haemorrhoidal haemorrhage 17.03 10.19 25 80480 8068 110500726
Chorea 17.01 10.19 16 80489 3219 110505575
Renal cell carcinoma 16.92 10.19 24 80481 7506 110501288
Clostridium difficile infection 16.88 10.19 79 80426 52050 110456744
Dysstasia 16.29 10.19 57 80448 32929 110475865
Sedation 16.27 10.19 16 80489 69667 110439127
Small intestinal obstruction 16.20 10.19 56 80449 32157 110476637
Transfusion 16.20 10.19 48 80457 25424 110483370
Apnoeic attack 16.10 10.19 9 80496 803 110507991
High frequency ablation 16.07 10.19 7 80498 363 110508431
Application site erythema 15.86 10.19 20 80485 5590 110503204
Hepatobiliary infection 15.82 10.19 4 80501 35 110508759
Lupus-like syndrome 15.79 10.19 5 80500 40787 110468007
Mental status changes 15.66 10.19 102 80403 76020 110432774
Abdominal symptom 15.64 10.19 9 80496 849 110507945
Right aortic arch 15.39 10.19 3 80502 6 110508788
Cerebellar haematoma 15.28 10.19 8 80497 626 110508168
Gastric antral vascular ectasia 15.28 10.19 10 80495 1187 110507607
Osteopenia 15.24 10.19 43 80462 22166 110486628
Polyhydramnios 15.13 10.19 12 80493 1921 110506873
Fluid retention 15.13 10.19 119 80386 94188 110414606
Urinary tract infection 15.11 10.19 327 80178 325955 110182839
Multiple organ dysfunction syndrome 15.10 10.19 58 80447 151652 110357142
Drug hypersensitivity 15.09 10.19 236 80269 453854 110054940
Hypomagnesaemia 15.03 10.19 85 80420 60285 110448509
Cerebrovascular accident 14.73 10.19 199 80306 181085 110327709
Flatulence 14.73 10.19 76 80429 52073 110456721
Lower limb fracture 14.68 10.19 20 80485 75328 110433466
Urinary incontinence 14.56 10.19 72 80433 48515 110460279
Skin neoplasm excision 14.47 10.19 12 80493 2046 110506748
Influenza like illness 14.42 10.19 112 80393 88300 110420494
Blood lactic acid 14.36 10.19 7 80498 471 110508323
Iron deficiency anaemia 14.28 10.19 53 80452 31506 110477288
Heart rate 14.24 10.19 6 80499 287 110508507
AST/ALT ratio abnormal 14.13 10.19 5 80500 148 110508646
Pulmonary embolism 14.12 10.19 227 80278 214247 110294547
Cellulitis 14.07 10.19 147 80358 125869 110382925
Gingival erosion 14.04 10.19 5 80500 151 110508643
Viral infection 14.02 10.19 76 80429 53063 110455731
Ear infection viral 13.98 10.19 5 80500 153 110508641
Coeliac disease 13.93 10.19 7 80498 43180 110465614
Complication associated with device 13.90 10.19 39 80466 20034 110488760
Nausea 13.86 10.19 1061 79444 1234629 109274165
Bone pain 13.85 10.19 88 80417 65045 110443749
Haemorrhoids thrombosed 13.69 10.19 6 80499 316 110508478
Confusional state 13.68 10.19 442 80063 468238 110040556
Gait inability 13.66 10.19 52 80453 136324 110372470
Infection 13.51 10.19 184 80321 362016 110146778
Laryngitis 13.49 10.19 7 80498 42404 110466390
Uterine leiomyoma 13.48 10.19 22 80483 7778 110501016
Eye pain 13.45 10.19 72 80433 50027 110458767
Narrow anterior chamber angle 13.39 10.19 5 80500 173 110508621
Vulvovaginal mycotic infection 13.38 10.19 18 80487 5359 110503435
Liver function test abnormal 13.35 10.19 91 80414 68859 110439935
Blindness cortical 13.32 10.19 9 80496 1126 110507668
Abdominal hernia 13.26 10.19 20 80485 6609 110502185
Rash pruritic 13.21 10.19 119 80386 97950 110410844
Failure to thrive 13.20 10.19 30 80475 13544 110495250
Hallucination 13.11 10.19 122 80383 101310 110407484
Anaphylactic shock 13.03 10.19 11 80494 51535 110457259
Occult blood positive 12.87 10.19 21 80484 7424 110501370
Hypoaesthesia oral 12.74 10.19 34 80471 16968 110491826
Transient ischaemic attack 12.72 10.19 85 80420 63897 110444897
Foot deformity 12.69 10.19 10 80495 48470 110460324
Multiple sclerosis relapse 12.68 10.19 71 80434 50169 110458625
Application site rash 12.66 10.19 12 80493 2438 110506356
Productive cough 12.60 10.19 133 80372 114172 110394622
Gastrointestinal disorder 12.56 10.19 114 80391 241838 110266956
Restless legs syndrome 12.55 10.19 43 80462 24583 110484211
Withdrawal of life support 12.51 10.19 4 80501 86 110508708
Cardiogenic shock 12.45 10.19 14 80491 57324 110451470
Parkinsonian rest tremor 12.45 10.19 6 80499 394 110508400
Blood sodium decreased 12.36 10.19 58 80447 38261 110470533
Left atrial dilatation 12.21 10.19 14 80491 3546 110505248
New onset diabetes after transplantation 12.15 10.19 6 80499 415 110508379
Blood albumin decreased 12.15 10.19 46 80459 27606 110481188
Pulmonary hypertension 11.98 10.19 75 80430 55145 110453649
Orthostatic hypotension 11.98 10.19 86 80419 66163 110442631
Inflammation 11.88 10.19 87 80418 193151 110315643
Bronchitis 11.80 10.19 170 80335 156862 110351932
Testicular haemorrhage 11.69 10.19 5 80500 248 110508546
Unresponsive to stimuli 11.65 10.19 83 80422 63707 110445087
Dependence on oxygen therapy 11.64 10.19 7 80498 716 110508078
Rheumatoid lung 11.62 10.19 15 80490 4289 110504505
Postural tremor 11.61 10.19 8 80497 1034 110507760
Product complaint 11.56 10.19 29 80476 13943 110494851
Acute respiratory distress syndrome 11.54 10.19 13 80492 53185 110455609
Heavy menstrual bleeding 11.54 10.19 32 80473 16333 110492461
Altered state of consciousness 11.53 10.19 15 80490 57611 110451183
Peripheral swelling 11.52 10.19 380 80125 403654 110105140
Sleep disorder 11.48 10.19 91 80414 198553 110310241
Injection site haemorrhage 11.40 10.19 51 80454 32977 110475817
Stress 11.33 10.19 39 80466 105309 110403485
Injury 11.29 10.19 79 80426 177186 110331608
Hypoxia 11.29 10.19 144 80361 129371 110379423
Myotonia 11.24 10.19 5 80500 273 110508521
Hepatotoxicity 11.21 10.19 18 80487 63382 110445412
Rebound acid hypersecretion 11.13 10.19 4 80501 124 110508670
Arthropathy 11.11 10.19 145 80360 287377 110221417
Cardio-respiratory arrest 11.07 10.19 45 80460 115791 110393003
Cardiac flutter 11.00 10.19 17 80488 5740 110503054
White blood cell count decreased 10.97 10.19 231 80274 229159 110279635
Neoplasm progression 10.81 10.19 19 80486 64576 110444218
Neuropathy peripheral 10.79 10.19 187 80318 179090 110329704
Haemorrhoids 10.78 10.19 53 80452 35619 110473175
Cholestasis 10.78 10.19 19 80486 64499 110444295
Neurotoxicity 10.68 10.19 9 80496 42198 110466596
Subdural haemorrhage 10.66 10.19 18 80487 6540 110502254
Reperfusion arrhythmia 10.66 10.19 5 80500 309 110508485
Product prescribing error 10.65 10.19 13 80492 51318 110457476
Polyneuropathy 10.61 10.19 5 80500 32007 110476787
Laryngeal pain 10.52 10.19 17 80488 5958 110502836
Application site pruritus 10.46 10.19 14 80491 4146 110504648
Condition aggravated 10.46 10.19 433 80072 734403 109774391
Haemophagocytic lymphohistiocytosis 10.35 10.19 5 80500 31554 110477240
Agitated depression 10.28 10.19 6 80499 581 110508213
Neutropenic sepsis 10.26 10.19 47 80458 30699 110478095
Infected neoplasm 10.20 10.19 6 80499 589 110508205

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC B03AA02 BLOOD AND BLOOD FORMING ORGANS
ANTIANEMIC PREPARATIONS
IRON PREPARATIONS
Iron bivalent, oral preparations
ATC B03AD02 BLOOD AND BLOOD FORMING ORGANS
ANTIANEMIC PREPARATIONS
IRON PREPARATIONS
Iron in combination with folic acid
MeSH PA D014131 Trace Elements
MeSH PA D018977 Micronutrients
CHEBI has role CHEBI:33282 antibacterial agent
CHEBI has role CHEBI:64946 anti-HIV agent
CHEBI has role CHEBI:75835 anti-anaemic agent

Related Drugs by ATC class:

B03AA Iron bivalent, oral preparations 8 drugs
ferrous ascorbateferrous aspartateferrous carbonateferrous chlorideferrous gluconateferrous succinateferrous sulfateferrous tartrate
B03AD Iron in combination with folic acid 3 drugs
ferrous gluconateferrous sulfatefolic acid

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Contraception indication 13197004
Anemia of prematurity indication 47100003 DOID:11243
Megaloblastic anemia due to folate deficiency indication 85649008 DOID:14026
Iron deficiency anemia indication 87522002
Acne vulgaris indication 88616000
Pregnancy, function indication 289908002
Breastfeeding (mother) indication 413712001
Amenorrhea off-label use 14302001 DOID:13938
Female hypogonadism syndrome off-label use 16041008
Polycystic ovaries off-label use 69878008
Endometriosis off-label use 129103003
Dysmenorrhea off-label use 266599000
Abnormal uterine bleeding unrelated to menstrual cycle off-label use 312984006
Menorrhagia off-label use 386692008
Prevention of Fetal Neural Tube Defects during Pregnancy off-label use
Heart valve disorder contraindication 368009 DOID:4079
Peptic ulcer contraindication 13200003 DOID:750
Hypercholesterolemia contraindication 13644009
Constipation contraindication 14760008 DOID:2089
Primary hyperoxaluria contraindication 17901006 DOID:2977
Hyperphosphatemia contraindication 20165001 DOID:0050459
Myocardial infarction contraindication 22298006 DOID:5844
Gastroenteritis contraindication 25374005 DOID:2326
Hypervitaminosis D contraindication 27712000 DOID:9971
Sarcoidosis contraindication 31541009 DOID:11335
Dehydration contraindication 34095006
Depressive disorder contraindication 35489007
Migraine contraindication 37796009 DOID:6364
Hypertensive disorder contraindication 38341003 DOID:10763
Hemosiderosis contraindication 39011001 DOID:12119
Disorder of gallbladder contraindication 39621005 DOID:0060262
Hypokalemia contraindication 43339004
Body fluid retention contraindication 43498006
Thrombosis of retinal vein contraindication 46085004
Gastrectomy contraindication 53442002
Hyperlipidemia contraindication 55822004 DOID:1168
Benign mammary dysplasia contraindication 57993004
Leber's optic atrophy contraindication 58610003 DOID:705
Obstructive hyperbilirubinemia contraindication 59848001
Hemolytic anemia contraindication 61261009 DOID:583
Thrombophlebitis contraindication 64156001 DOID:3875
Ulcerative colitis contraindication 64766004 DOID:8577
Intermenstrual bleeding - irregular contraindication 64996003
Hypercalcemia contraindication 66931009 DOID:12678
Hyperparathyroidism contraindication 66999008 DOID:13543
Diabetes mellitus contraindication 73211009 DOID:9351
Hyperglycemia contraindication 80394007 DOID:4195
Atrophic gastritis contraindication 84568007 DOID:8929
Kidney disease contraindication 90708001 DOID:557
Malignant neoplasm of liver contraindication 93870000 DOID:3571
Kidney stone contraindication 95570007
Anemia due to enzyme deficiency contraindication 111577008
Hb SS disease contraindication 127040003 DOID:10923
Deep venous thrombosis contraindication 128053003
Liver function tests abnormal contraindication 166603001
Angina pectoris contraindication 194828000
Osteolysis contraindication 203522001
Cerebrovascular accident contraindication 230690007
Pulmonary thromboembolism contraindication 233935004
Disease of liver contraindication 235856003 DOID:409
Cholestasis of pregnancy contraindication 235888006
Endometrial carcinoma contraindication 254878006 DOID:2871
Hypertriglyceridemia contraindication 302870006
Arteriosclerosis obliterans contraindication 361133006 DOID:5160
Malignant tumor of cervix contraindication 363354003 DOID:4362
Thromboembolic disorder contraindication 371039008
Cardiovascular event risk contraindication 395112001
Diverticular disease contraindication 397881000
Hemochromatosis contraindication 399187006 DOID:2352
Disorder of coronary artery contraindication 414024009
Obesity contraindication 414916001 DOID:9970
Estrogen receptor positive tumor contraindication 416053008
Porphyria contraindication 418470004
Hypertensive urgency contraindication 443482000
Carcinoma of female breast contraindication 447782002
Smokes tobacco daily contraindication 449868002
Nonspecific Abnormal Papanicolaou Smear of Cervix contraindication
Repeated Blood Transfusions contraindication
Major Surgery with Prolonged Post-Operative Immobilization contraindication




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
4017694 VUID
N0000146068 NUI
D01194 KEGG_DRUG
4017630 VANDF
4017694 VANDF
4028811 VANDF
C0060276 UMLSCUI
CHEBI:31607 CHEBI
CHEMBL1200640 ChEMBL_ID
DB14491 DRUGBANK_ID
C031621 MESH_SUPPLEMENTAL_RECORD_UI
R5L488RY0Q UNII
6433164 PUBCHEM_CID
24941 RXNORM
4723 MMSL
4919 MMSL
6955 MMSL
d03920 MMSL
000833 NDDF
387289009 SNOMEDCT_US
52108005 SNOMEDCT_US

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
BACMIN HUMAN PRESCRIPTION DRUG LABEL 19 0682-3001 TABLET, COATED 27 mg ORAL UNAPPROVED DRUG OTHER 10 sections
O-Cal Prenatal Vitamin HUMAN PRESCRIPTION DRUG LABEL 16 0813-0202 TABLET 15 mg ORAL UNAPPROVED DRUG OTHER 6 sections
PRENATAL PLUS HUMAN PRESCRIPTION DRUG LABEL 15 10544-549 TABLET, FILM COATED 27 mg ORAL unapproved drug other 8 sections
Se-Natal 19 HUMAN PRESCRIPTION DRUG LABEL 15 13925-116 TABLET 29 mg ORAL unapproved drug other 15 sections
Se-Natal 19 Chewable HUMAN PRESCRIPTION DRUG LABEL 14 13925-117 TABLET, CHEWABLE 29 mg ORAL unapproved drug other 16 sections
Se-Tan PLUS HUMAN PRESCRIPTION DRUG LABEL 13 13925-118 CAPSULE, GELATIN COATED 162 mg ORAL unapproved drug other 18 sections
PRENATAL PLUS HUMAN PRESCRIPTION DRUG LABEL 15 17856-0668 TABLET, FILM COATED 27 mg ORAL UNAPPROVED DRUG OTHER 6 sections
C-Nate DHA HUMAN PRESCRIPTION DRUG LABEL 13 23359-105 CAPSULE, GELATIN COATED 28 mg ORAL unapproved drug other 15 sections
Prenatal Plus Vitamins HUMAN PRESCRIPTION DRUG LABEL 15 39328-106 TABLET 27 mg ORAL UNAPPROVED DRUG OTHER 7 sections
PNV-Select HUMAN PRESCRIPTION DRUG LABEL 18 42192-320 TABLET, FILM COATED 27 mg ORAL unapproved drug other 10 sections
PNV-DHA HUMAN PRESCRIPTION DRUG LABEL 10 42192-321 CAPSULE, GELATIN COATED 27 mg ORAL unapproved drug other 11 sections
PNV-DHA HUMAN PRESCRIPTION DRUG LABEL 8 42192-323 CAPSULE, GELATIN COATED 27 mg ORAL unapproved drug other 11 sections
PNV-Omega HUMAN PRESCRIPTION DRUG LABEL 13 42192-332 CAPSULE, GELATIN COATED 28 mg ORAL unapproved drug other 12 sections
PNV Prenatal VitaminPlus Vitamin A HUMAN PRESCRIPTION DRUG LABEL 12 44946-1046 TABLET 27 mg ORAL UNAPPROVED DRUG OTHER 9 sections
Prenatal Vitamins Plus Low Iron HUMAN PRESCRIPTION DRUG LABEL 15 50090-0616 TABLET 27 mg ORAL UNAPPROVED DRUG OTHER 8 sections
PNV Prenatal Plus Multivitamin HUMAN PRESCRIPTION DRUG LABEL 15 50090-0617 TABLET 27 mg ORAL Unapproved drug other 9 sections
Concept OB HUMAN PRESCRIPTION DRUG LABEL 15 52747-620 CAPSULE 42.50 mg ORAL unapproved drug other 13 sections
Concept DHA HUMAN PRESCRIPTION DRUG LABEL 15 52747-621 CAPSULE, LIQUID FILLED 17.50 mg ORAL unapproved drug other 7 sections
Integra F HUMAN PRESCRIPTION DRUG LABEL 5 52747-711 CAPSULE 62.50 mg ORAL unapproved drug other 14 sections
Integra Plus HUMAN PRESCRIPTION DRUG LABEL 10 52747-712 CAPSULE 62.50 mg ORAL unapproved drug other 12 sections
M-Natal Plus HUMAN PRESCRIPTION DRUG LABEL 14 58657-170 TABLET 27 mg ORAL unapproved drug other 7 sections
M-Natal Plus HUMAN PRESCRIPTION DRUG LABEL 14 58657-170 TABLET 27 mg ORAL unapproved drug other 7 sections
Finazol HUMAN PRESCRIPTION DRUG LABEL 24 59088-008 TABLET 18 mg ORAL unapproved drug other 13 sections
Prenatol-M HUMAN PRESCRIPTION DRUG LABEL 20 59088-009 TABLET 27 mg ORAL unapproved drug other 13 sections
Boostervite HUMAN PRESCRIPTION DRUG LABEL 16 59088-022 TABLET 18 mg ORAL unapproved drug other 15 sections
PureVit DualFe Plus HUMAN PRESCRIPTION DRUG LABEL 13 59088-112 CAPSULE 53 mg ORAL unapproved drug other 12 sections
Vitalux HUMAN PRESCRIPTION DRUG LABEL 20 59088-139 TABLET 27 mg ORAL unapproved drug other 13 sections
Vitrexyl plus Iron HUMAN PRESCRIPTION DRUG LABEL 18 59088-165 TABLET 27 mg ORAL unapproved drug other 13 sections
Prenatrix HUMAN PRESCRIPTION DRUG LABEL 20 59088-166 TABLET 27 mg ORAL unapproved drug other 13 sections
Vitrexate FE HUMAN PRESCRIPTION DRUG LABEL 18 59088-168 TABLET 27 mg ORAL unapproved drug other 13 sections